MulV

120-150nm

 

The company’s top priority is the health of patients -
safety always comes first.

HIV

100-120nm

 

REO-3

75nm

 

EBV

80-100nm

 

HBV

42nm

 

HAV

25-30nm

 

Polio Virus

28-30nm

 

15nm nanofiltration removes even the smallest plasma derived virus, Parvovirus B19

18-26nm

Ebola

80x800nm

 

Quality & Safety

 

Oxbridge is dedicated to supplying high-quality and safe biopharmaceuticals to save lives and improve the quality of life for patients who Suffer from rare and life-threatening diseases. The technologies employed in the manufacturing process of the products reflect our corporate dedication to quality and safety. 
It is our upmost priority to take care of people very seriously who use our lifesaving therapies. We are proud to meet or exceed the international standards for product safety in accordance with regulatory authorities worldwide. We believe our products are safer than ever before owing to stringent measures taken in product safety, manufacturing technologies, and research and development activities.

Quality Management System

 

Additionally, Oxbridge has in place its own internal Quality Management System. This not only monitors the use and safety of our own products, but also compares our performance and processes with those of other similar organisations ensuring that Oxbridge’s products are always at the leading edge and that our patients consistently receive the best possible service.

Oxbridge Pharma Ltd

15 Fitzroy House, Lynwood Drive, Worcester Park, Sutton, Surrey KT4 7AT, United Kingdom

T +44 208 335 4110 | F +44 208 335 4118 | enquiries@oxbridgepharma.com

Copyright © 2019 Oxbridge Pharma Ltd. All rights reserved.

Designed by jundesign